Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer
发布时间：2019-05-13 分享到：
… The design of the assay and single nucleotide polymorphism genotyping were performed by Bio Miao Biological Technology (Beijing, China) using the Sequenom MassARRAY platform (Sequenom, San Diego, CA, USA) according to the manufacturer instructions …
上一篇：A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 …
下一篇：Association between single nucleotide polymorphisms in NFATC1 signaling pathway genes and susceptibility to congenital heart disease in the Chinese population
返回列表
相关推荐
- Increased osteogenesis in osteoporotic bone marrow stromal cells by ove2019-05-13
- Targeted P2X7R shRNA delivery attenuates sympathetic nerve sprouting an2019-05-13
- TNF-a (-238G/A and -308G/A) gene polymorphisms may not contribute to t2019-05-13
- Genetic polymorphisms in Sox17 associated with intracranial aneurysm in2019-05-13
- Association of ENAM, TUFT1, MMP13, IL1B, IL10 and IL1RN gene poly2019-05-13
- miR-509-3p enhances platinum drug sensitivity in ovarian cancer2019-05-13